U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660536) titled 'To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study' on June 16.

Brief Summary: A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women

Study Start Date: Nov. 14, 1989

Study Type: INTERVENTIONAL

Condition: Bone Mineral Density of Spine and Femur

Intervention: DRUG: doxercalciferol capsules, Hectorol(R)

doxercalciferol capsules given in escalating doses from 1mcg to 5mcg daily.If serum calcium is elevated at any dose then that dose is maintained long ...